Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

NCT03235024 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis Eczema

Interventions

BIOLOGICAL: B244
BIOLOGICAL: Vehicle

Sponsor

AOBiome LLC

Collaborators

[object Object]